Status:

RECRUITING

Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Conditions:

Echinococcosis

Diagnosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Echinococcosis is a severe parasitosis caused by the development of the tapeworm larva Echinococcus multilocularis, responsible for alveolar echinococcosis (AE) or Echinococcus granulosus, responsible...

Eligibility Criteria

Inclusion Criteria:

  • Men and women aged >18 years with a diagnosis of echinococcosis (Alveolar Echinococcosis or Cystic Echinococcosis) established according to the reference criteria
  • Signature of the informed consent form indicating that the subject has understood the purpose and the procedures required by the study and that he agrees to participate in the study and to comply with the requirements and restrictions about this study
  • Affiliation to a French social security scheme or beneficiary of such a scheme.

Exclusion Criteria:

  • Legal incapacity or limited legal capacity
  • Subject unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
  • Subject without health insurance
  • Pregnant woman
  • Subject being in the period of exclusion from another study or provided by the "national volunteer file".

Key Trial Info

Start Date :

October 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT05824442

Start Date

October 24 2023

End Date

October 1 2026

Last Update

February 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MILLON

Besançon, France, 25000

Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis | DecenTrialz